Overview
Overview :: Program Book :: Floorplan :: Poster Table
Program Overview
Updated: 19.09. : Updates due to cancelations and replacements.
Program Book
Updated: 191.09.2024 Updates due to cancelations and replacements.
A printed version of the Programbook with the detailed program will be handed out to all participants during the onsite registration. A PDF version of this programbook is also available for download here:
f
Abstract Book
Please note that to save paper the full Abstractbook with all abstracts and particpants list will only available online as PDF to registered participants after login to the registration system.
Poster Table:
Latest Update 11.9.24: Typo corrected
Posters are assigned to one of the 2 poster sessions. All posters will be on display for the whole meeting.
Poster presenters: Please be present at your poster during your respective poster session.
Download the Poster table as a PDF.
Floor plan
Tue 17.9.
Updated: 19.09. : Updates due to cancelations and replacements.
Tuesday, September 17th, 2024
|
09:40 - 10:40 |
ÖGMBT General Assembly
|
ReSoWi HS 15.03 |
11:00 - 11:20 |
Opening Ceremony
Moderation: Helmut Bergler (University Graz, AT), Tobias Eisenberg (University of Graz, AT), Harald Pichler (Graz University of Technology AT)
|
UB Alumni HS |
11:20 - 12:00 |
Plenary Session 1
Chair: Sabine Kienesberger-Feist (University of Graz, AT)
|
UB Alumni HS |
11:20 - 12:00 |
Anne Müller (Universität Zürich, CH)
Mechanisms of infection-induced cancer illustrated by the H. pylori/gastric cancer paradigm
|
|
12:00 - 12:20 |
Science Flashes 1
Chair: Gregor Gorkiewicz (Medical University of Graz, AT)
|
UB Alumni HS |
|
Felix Sternberg (University of Vienna, AT)
Transcriptional effects of medium-chain fatty acids (C8 and C10) under a ketogenic diet mimic intermittent fasting in mice
|
|
|
Daniel Waltenstorfer (Karl-Franzens Universität Graz, AT)
De novo Lipogenesis in the regulation of autophagy in aging yeast
|
|
|
Petra Huber-Cantonati (PMU Salzburg, AT)
Dihydrochalcones: exploring natural compound derivatives for cancer therapy
|
|
12:20 - 13:00 |
Lunch
|
UB & ReSoWi |
13:00 - 14:30 |
Poster Session 1
|
ReSoWi |
14:40 - 15:55 |
S1: One health from a microbial perspective
Chairs: Christine Moissl-Eichinger (Medical University of Graz, AT), Angela Sessitsch (AIT Austrian Institute of Technology, AT)
|
UB Alumni HS |
14:40 - 15:10 |
Angela Sessitsch (AIT Austrian Institute of Technology, AT)
Plant microbiota from rhizosphere to seeds – ecology, applications and link to the food system
|
|
15:10 - 15:25 |
Isabella Faimann (Medical University Graz, AT)
Environmental enrichment reduces anxiety-like behaviour and changes the microbial community composition of mice
|
|
15:25 - 15:55 |
Christine Moissl-Eichinger (Medical University of Graz, AT)
The human archaeome in the context of global methane emissions
|
|
14:40 - 15:55 |
S2: Improved in vitro models: animal experiment replacement strategies
Chairs: Sebastian Schwaminger (Medical University of Graz, AT), Nassim Ghaffari-Tabrizi-Wizsy (Medical University of Graz, AT)
|
ReSoWi HS 15.03 |
14:40 - 15:10 |
Wilfried Posch (Medical University of Innsbruck, AT)
Investigating fungal and viral infections using immune-competent human respiratory barrier models
|
|
15:25 - 15:40 |
Julia Dreger (Leibniz Universität Hannover, DE)
Development of a scalable and semi-automated bioreactor process for 3D osteogenic differentiation of human MSCs
|
|
15:40 - 15:55 |
Nassim Ghaffari (Medical University of Graz, AT)
CAM assay as a relaible method in biomedical science
|
|
15:55 - 16:15 |
Coffee Break
|
UB & ReSoWi |
16:15 - 17:30 |
S3: Infection & Immunity
Chairs: Sabine Kienesberger-Feist (University of Graz, AT), Gregor Gorkiewicz (Medical University of Graz, AT)
|
UB Alumni HS |
16:15 - 16:45 |
Anouk Willemsen (University of Vienna, AT)
The evolution of virus genes and genomes
|
|
16:45 - 17:00 |
Ellen L. Zechner (University of Graz, AT)
Microbiota-derived small molecule genotoxins: powerful effectors of the gut ecosystem
|
|
17:00 - 17:15 |
Katharina Pütz (BOKU University, AT)
Staphylococcus aureus adhesion and viability decrease on antimicrobial peptide SAAP-148 – DNA based multilayer coatings for orthopedic implants
|
|
17:15 - 17:30 |
Vera Fengler (University of Graz, Institute of Molecular Biosciences, AT)
Transcriptional regulation of Vibrio cholerae’s hemagglutinin/protease by TyrR
|
|
16:15 - 17:30 |
S4: Metabolic engineering of microbes
Chairs: Michael Sauer (OMV AG, AT), Anita Emmerstorfer-Augustin (Graz University of Technology, AT)
|
ReSoWi HS 15.03 |
16:15 - 16:45 |
Simon Arhar (University of Graz, AT)
Optimization of β-carotene synthesis in Saccharomyces cerevisiae
|
|
16:45 - 17:00 |
Spase Stojanov (Jožef Stefan Institute, SI)
Incorporation of genetically modified vaginal lactobacilli into electrospun nanofibers and their interaction with human epithelial cells
|
|
17:00 - 17:15 |
Golnaz Memari (Universität für Bodenkultur (BOKU), AT)
Pathway Design for Mixotrophic Production of Chemicals from CO2 and Methanol in Yeasts
|
|
17:15 - 17:30 |
Matthias Steiger (TU Wien, AT)
Characterization of a synthetic, linear pathway for methanol assimilation based on formolase in Komagataella phaffii
|
|
17:40 - 18:20 |
Life Sciences Awards Austria 2024
Moderator: Michael Sauer (OMV AG, AT)
|
ReSoWi HS 15.03 |
|
LIFE SCIENCES RESEARCH AWARDS 2024 CEREMONY
Opening words by Ulrike Unterer (BMAW, AT)
Research Award winners:Chiara M. Herzog, Cathrine Hellerschmied & Elma Dervic. The Research Award winners will present their work during the RISING STAR LECTURES session on Sept. 18th at 9:00
|
|
|
LIFE SCIENCES PHD AWARDS 2024 CEREMONY & LECTURES
Life Science PhD Award Austria 2024 – Basic Science
Belén Pacheco Fiallos (IMP, AT)
Nuclear mRNA recognition and packaging by the transcription and export complex.
|
|
|
Life Sciences PhD Award Austria 20243 – Applied Research
Michael Baumschabl (ACIB GmbH, AT)
Increasing efficiency of CO2 assimilation in synthetic autotrophic Komagataella phaffii
|
|
18:20 - 19:00 |
Plenary Session 2
Chair: Harald Pichler (Graz University of Technology AT)
|
ReSoWi HS 15.03 |
18:20 - 19:00 |
Susan Gasser (ISREC Foundation and University of Lausanne, CH)
Epigenetics in real time: how a loss of heterochromatin increases genome instability in aging and cancer
|
|
19:00 - 22:00 |
Wine & Science
|
UB & ReSoWi |
Wed 18.9.
Wednesday, September 18th, 2024
|
09:00 - 09:40 |
Rising Star Lectures
Chair: Joachim Seipelt (Jury chair, Nuvonis Technologies GmbH, AT)
|
UB Alumni HS |
|
Life Sciences Research Award Austria 2024 – Basic Science
Chiara M. Herzog (Universität Innsbruck, AT)
Cigarette smoking and e-cigarette use induce shared DNA methylation changes linked to carcinogenesis
|
|
|
Life Sciences Research Award Austria 2024 – Applied Research
Cathrine Hellerschmied (University of Vienna, AT)
Hydrogen storage and geo-methanation in a depleted underground hydrocarbon reservoir
|
|
|
Life Sciences Research Award Austria 2024 – Excellence & Societal Impact
Elma Dervic (Medical University Vienna & Complexity Science Hub, AT)
Unraveling cradle-to-grave disease trajectories from multilayer comorbidity networks
|
|
09:40 - 10:25 |
PhD Session
Chairs: Magdalena Gerhalter (University of Graz, AT), Simon Kobalter (Graz University of Technology, AT)
|
UB Alumni HS |
09:40 - 09:55 |
Jakob Proemer (Medical University of Vienna, AT)
Muscle specific kinase is a substrate for calcium/calmodulin-dependent protein kinase II beta in the peripheral nervous system
|
|
09:55 - 10:10 |
Marco Reindl (Medical University of Graz, AT)
Adsorption dynamics of Lasioglossin-III on polymer-coated iron oxide nanoparticles.
|
|
10:10 - 10:25 |
Julian Sommersguter-Wagner (University of Graz, AT)
Sugar induced lifespan reduction is linked to ceramides
|
|
10:25 - 10:45 |
Science Flashes 2
Chair: Helmut Bergler (University Graz, AT)
|
UB Alumni HS |
|
Andrea Jerkovic (University of Graz, AT)
Polyamine pathway plays a central role in sleep regulation
|
|
|
Sophie Schmid (Medizinische Universität Graz, AT)
Role of autophagy-related protein ATG4b in cardiovascular homeostasis during aging
|
|
|
Melanie Müller (Institute of Molecular Biosciences, AT)
A novel platform revealed the natural polyphenol rutin to prolong the healthspan of D. melanogaster upon a high-sugar diet
|
|
|
Satinee Xuying Loh (Medical University of Graz, AT)
Expression and purification of histidine and (HR)4 tagged PETase for immobilisation onto magnetic iron oxide nanoparticles and subsequent microplastics capture in wastewater
|
|
|
Tobias Madl (Medical University of Graz, AT)
Deciphering the intricate role of intrinsically disordered regions in transcription factor regulation
|
|
|
Daniela Weber (University Hospital of the Paracelsus Medical University, AT)
Ketogenic diet enhances the anti-tumor effect of mifepristone in a breast cancer mouse model
|
|
10:45 - 11:05 |
Coffee Break
|
UB & ReSoWi |
11:05 - 12:20 |
S5: Lipids in Health and Disease
Chairs: Martina Schweiger (University of Graz, AT), Katrin Watschinger (Medical University of Innsbruck, AT)
|
UB Alumni HS |
11:05 - 11:35 |
Elina Ikonen (University of Helsinki, FI)
Control of organelle identity and cell viability by a lipid phosphatase
|
|
11:35 - 11:50 |
Sandra Alohan (University of Graz, AT)
Lipids of the skin: Investigating the metabolism of ultra-long chain triacylglycerol estolides
|
|
11:50 - 12:05 |
Michael Ebner (Leibniz-Forschungsinstitut für Molekulare Pharmakologie, DE)
Nutrient-regulated control of lysosome function by signaling lipid conversion
|
|
12:05 - 12:20 |
Ilaria Dorigatti (Medical University Innsbruck, AT)
Plasmalogens unveiled: impact on the hematopoietic and immune system
|
|
11:05 - 12:20 |
S6: Novel antibiotic & antifungal strategies
Chairs: Didac Carmona-Gutierrez (University of Graz, AT), Günther Koraimann (Universität Graz, AT)
|
ReSoWi HS 15.03 |
11:05 - 11:35 |
Carol Munro (University of Aberdeen, GB)
Fungal cell wall remodelling in response to antifungal drug therapy: opportunities for new antifungal therapies
|
|
11:35 - 11:50 |
Sarah Sedik (Medical University of Graz, AT)
Clinical Experience with new glucan synthesis inhibitors for Treatment of Patients with Candida infections
|
|
11:50 - 12:05 |
Nermina Malanovic (University of Graz, AT)
Peptide-Based Therapies for Bacterial Infections and Cancer: Novel Insights and Potential
|
|
12:05 - 12:20 |
Marjanca Starčič Erjavec (Biotechnical Faculty, University of Ljubljana, SI)
Antimicrobial and anticancer effects of human amniotic membrane
|
|
12:20 - 13:00 |
Lunch
|
UB & ReSoWi |
13:00 - 14:00 |
Poster Session 2
|
ReSoWi |
14:00 - 15:15 |
S7: Routes to healthy aging - basic research
Chairs: Sebastian Hofer (Max-Delbrück-Center for Molecular Medicine in the Helmholtz Association (MDC), DE), Jelena Tadic (University of Graz, AT)
|
UB Alumni HS |
14:00 - 14:30 |
Nektarios Tavernarakis (1. Foundation for Research and Technology - Hellas. 2. University of Crete., GR)
Mitophagy and mitochondrial biogenesis in ageing and neurodegeneration.
|
|
14:30 - 14:45 |
Markus Schosserer (Medical University of Vienna, AT)
The role of the ribosomal RNA methyltransferase Nsun5 in aging and physiology of mice
|
|
14:45 - 15:00 |
Eleonora Nardini (Medical University of Vienna, AT)
Accumulation of senescent endothelial cells promotes atherosclerosis and impairs cardiac function
|
|
15:00 - 15:15 |
Andreas Zimmermann (University of Graz, AT)
Unexpected dual function of an E3 ligase in aging-related proteostasis
|
|
14:00 - 15:15 |
S8: Innovative Treatment for Diseases
Chairs: Stefan Kubicek (CeMM Research Center for Molecular Medicine of the Austrian Academy of Sciences, AT), Joachim Seipelt (Nuvonis Technologies GmbH, AT)
|
ReSoWi HS 15.03 |
14:00 - 14:30 |
Pavel Mykhailiuk (Enamine, UA)
Saturated benzene bioisosteres
|
|
14:30 - 14:45 |
Magdalena Gerhalter (University of Graz, AT)
The novel ribosome biogenesis inhibitor usnic acid blocks nucleolar pre-60S maturation
|
|
14:45 - 15:00 |
Karin Schelch (Medical University of Vienna, AT)
Striking the powerhouse: Identification of unique metabolic phenotypes as subtype-specific therapeutic vulnerabilities in small cell lung cancer
|
|
15:00 - 15:15 |
Lena Parigger (Innophore GmbH, AT)
CavitOmiX Drug Discovery: Discovering and Engineering Antivirals towards Enhanced Spectrum and Reduced Side Effects
|
|
15:15 - 15:30 |
Coffee Break
|
UB & ReSoWi |
15:30 - 16:45 |
S9: RNA biology
Chairs: Alexandra Lusser (Medical University of Innsbruck, AT), Brigitte Pertschy (University of Graz, AT)
|
UB Alumni HS |
15:30 - 16:00 |
Sebastian Leidel (University of Bern, CH)
Can tRNA modifications kill an elephant?
|
|
16:00 - 16:15 |
Maximilian Schmid-Siegel (Medical University of Vienna, AT)
Cellular senescence affects the epitranscriptome of skin cells
|
|
16:15 - 16:30 |
Ângela Marques (Medical University of Vienna, AT)
Optimizing site-directed RNA editing of Filamin A to ameliorate cardiovascular disease, colitis, and tumor growth
|
|
16:30 - 16:45 |
Ingrid Zierler (University of Graz, AT)
Novel key function of Rps15 (uS19) in cytoplasmic ribosomal 40S subunit assembly
|
|
15:30 - 16:45 |
S10: Protein evolution & biocatalysis
Chairs: Daniel Kracher (Graz University of Technology, AT), Stefan Hofbauer (BOKU University, AT)
|
ReSoWi HS 15.03 |
15:30 - 16:00 |
Gustav Vaaje-Kolstad (Norwegian University of Life Sciences, NO)
The role of lytic polysaccharide monooxygenases as virulence factors
|
|
16:00 - 16:15 |
Margit Winkler (TUGraz, AT)
Chopping C=C bonds: characterization and engineering of a new dioxygenase
|
|
16:15 - 16:30 |
Anja Kostelac (BOKU, AT)
Modifying the oligomeric state of dimeric pyranose oxidase to alter substrate specificity towards glycosides
|
|
16:30 - 16:45 |
Jasmin Zuson (TU Graz, AT)
Deciphering the context dependency in enzyme evolution of borneol-type dehydrogenases
|
|
16:50 - 17:30 |
Plenary Session 3
Chair: Tobias Eisenberg (University of Graz, AT)
|
ReSoWi HS 15.03 |
16:50 - 17:30 |
Valter D. Longo (University of Southern California, US)
Fasting Mimicking Diets in Longevity and Disease
|
|
17:40 - 17:45 |
Group Photo |
17:40 - 22:00 |
City walk & Rooftop ReceptionSchlossberg/Café Freiblick
|
Thu 19.9.
Thursday, September 19th, 2024
|
09:00 - 09:40 |
Plenary Session 4
Chair: Tobias Eisenberg (University of Graz, AT)
|
ReSoWi HS 15.03 |
09:00 - 09:40 |
Susan Howlett (Dalhousie University, CA)
A frailty index to quantify frailty in preclinical models: new tools in translational geroscience
|
|
09:40 - 10:45 |
ÖGMBT YLSA Session: Building Resilience – coping with crises and stress
Chair: Lydia Riepler (Medical University of Innsbruck, AT)
|
ReSoWi HS 15.03 |
09:40 - 10:20 |
Nataliia Maronchuk (Medical University of Innsbruck, University Clinic for Psychiatry I, AT)
Building Resilience – coping with crises and stress
|
|
10:45 - 11:05 |
Coffee Break
|
UB & ReSoWi |
11:05 - 11:20 |
S11: Systemic effects of cancer: the role of the micro- and macroenvironment in tumor development and progression
Chairs: Juliane Winkler (Medical University of Vienna, AT), Alexander Deutsch (Medical University of Graz, AT)
|
UB Alumni HS |
11:05 - 11:35 |
Juliane Winkler (Medical University of Vienna, AT)
Dissecting the impacts of tumor heterogeneity on metastasis and metastatic niches one cell at a time.
|
|
11:35 - 11:50 |
Shweta Tikoo (Medical University of Vienna, AT)
Identification of a novel tumour macrophage progenitor
|
|
11:50 - 12:05 |
Jelena Krstic (Medical University of Graz, AT)
The metabolic role of p53 in hepatocellular carcinoma
|
|
12:05 - 12:20 |
Büsra Ernhofer (Medical University of Vienna, AT)
Impact of Polystyrene Micro- and Nanoplastic Particles on Lung Cancer Development and Progression
|
|
11:05 - 12:20 |
S12: AI-driven Research & Applications in Biosciences
Chairs: Robert Kourist (Graz University of Technology, AT), Gustav Oberdorfer (Institute of Biochemistry, Graz University of Technology, AT)
|
ReSoWi HS 15.03 |
11:05 - 11:35 |
David Schönauer (Aminoverse, NL)
AI for enzyme engineering: what (not) to expect from models predicting beneficial mutations to design the enzymes of tomorrow?
|
|
11:35 - 11:50 |
Gregor Wirnsberger (University of Graz, AT)
Flattening the curve - How to get better results with small deep- mutational-scanning datasets
|
|
11:50 - 12:05 |
Adrian Tripp (Graz University of Technology, AT)
Computational design of highly active enzymes
|
|
12:05 - 12:20 |
Florian Wieser (Graz University of Technology, AT)
Assessing the quality of loops in predicted protein structures
|
|
12:20 - 13:20 |
Lunch
|
UB & ReSoWi |
12:50 - 13:20 |
Workshop: Glacios 2 and SmartEPU automation for accessible, high-throughput structure determination and drug discovery
by Javier Fernandez Collado (Thermo Fisher Scientific)
|
UB Alumni HS |
12:50 - 13:20 |
Workshop: LabBuddy: Transform Your Laboratory Education with a Cutting-Edge Digitalization Tool
by Anita Emmerstorfer-Augustin (TUG) & Robert Kourist (TUG)
|
ReSoWi HS 15.03 |
13:30 - 14:45 |
S13: Routes to healthy aging – interventions & medical application
Chairs: Andreas Prokesch (Medical University Graz, AT), Simon Sedej (Medical University of Graz, AT)
|
UB Alumni HS |
13:30 - 14:00 |
Johannes Grillari (Ludwig Boltzmann Institute for Traumatology, AT)
Senescent cells and how to find and eliminate them
|
|
14:00 - 14:15 |
Leonie Mikolasch (Institute of Molecular Biosciences, AT)
The role of lipolysis in intermittent fasting-induced longevity
|
|
14:15 - 14:30 |
Irena Yordanova (Medical University of Vienna, AT)
Targeting miR-34 to reduce senescence in endothelial cells: potential therapy for cardiovascular and age-related diseases
|
|
14:30 - 14:45 |
Doruntina Bresilla (Medical University of Graz, AT)
The interrelation between Ca2+ and ROS homeostasis during aging
|
|
13:30 - 14:45 |
S14: Cellular networks
Chairs: Nikolaus Fortelny (University of Salzburg, AT), Ulrich Stelzl (University of Graz, AT)
|
ReSoWi HS 15.03 |
13:30 - 14:00 |
Cecilia Dominguez Conde (Human Technopole, IT)
Single-cell genomics to dissect developmental immunology
|
|
14:00 - 14:15 |
Georg Vucak (Max Perutz Labs, AT)
A Reference Map of the Erk Pathway Interactome Protein-protein interactions in the ERK pathway and their perturbation by oncogenic mutations
|
|
14:15 - 14:30 |
Jose Miguel Ramos Pittol (University of Innsbruck, AT)
Dual mode of transcriptional activation by the bile acid receptor FXR in liver cells: RXR independency occurs at non-canonical response elements
|
|
14:30 - 14:45 |
Eldi Sulaj (BOKU University, AT)
Quantitative proteomic analysis of cellular responses to stress induction in CHO cells
|
|
14:55 - 15:05 |
Coffee Break (UB & ReSoWi) & 1. Quiz drawing (ReSoWi)
|
|
15:05 - 16:20 |
S15: Protein Structure to Function
Chairs: Tea Pavkov-Keller (University of Graz, AT), David Haselbach (Research Institute of Molecular Pathology, AT)
|
UB Alumni HS |
15:05 - 15:35 |
Florian Schur (Institute of Science and Technology Austria, AT)
"Lifting" the curtain on the molecular architecture of extracellular matrix using cryo-electron tomography
|
|
15:35 - 15:50 |
Pedro A Sanchez Murcia (Medical University of Graz, AT)
Navigating the mutational landscape in enzymes using chemical dynamics
|
|
15:50 - 16:05 |
Christoph Grininger (University of Graz, AT)
SymProFold - Structural prediction of symmetrical biological assemblies
|
|
16:05 - 16:20 |
George Kobakhidze (Max Perutz Labs, Vienna BioCenter, AT)
Targeting mycolic acid biosynthesis in Mycobacterium tuberculosis: structure and mechanism of methyltransferase MmaA1
|
|
15:05 - 16:20 |
S16: Biorefineries & bioprocess technology
Chairs: Doris Ribitsch (BOKU University, AT), Regina Kratzer (Graz University of Technology, AT)
|
|
15:05 - 15:35 |
Georg Guebitz (BOKU University, AT)
Biorecycling of complex materials
|
ReSoWi HS 15.03 |
15:35 - 15:50 |
Marco Eigenfeld (Medical University Graz, AT)
Innovative scalable techniques for Saccharomyces yeast age fractionation
|
|
15:50 - 16:05 |
Anna Maria Erian (BOKU University, AT)
Altering the glucose uptake system of Serratia marcescens to enable co-cultivations for 2-butanol production
|
|
16:05 - 16:20 |
Andrea Graf (University of Vienna, AT)
Beyond exponential: exploring effective alternative feeding strategies in fed-batch fermentation
|
|
16:30 - 17:10 |
Plenary Session 5
Chair: David Haselbach (Research Institute of Molecular Pathology, AT)
|
UB Alumni HS |
16:30 - 17:10 |
Andy Martin (UC Berkeley, Howard Hughes Medical Institute, US)
Destruction with high specificity: New insights into the mechanisms of ubiquitin-dependent and -independent protein degradation by the 26S proteasome.
|
|
17:10 - 17:45 |
Closing Ceremony Best Talk/Poster prizes & 2nd Quiz drawing
Moderation: Helmut Bergler (University Graz, AT), Tobias Eisenberg (University of Graz, AT), Harald Pichler (Graz University of Technology AT)
|
UB Alumni HS |
Eric de Groot, MindMeeting BV, NL
Eric de Groot, MindMeeting BV, is one of the first Meeting Designers. His pioneering work started in 1992; now he caters to the national (Dutch) market in his company De Wet van Thomas and internationally in MindMeeting BV. Thanks to his background in drama he takes a broad, human perspective to meetings and meeting processes. He sees meetings as potentially strong catalysts of success if action is involved in them. “Listening to presentations is only the beginning of learning and change“: he says. His meeting designs involve tailor-made interactions, crowdsourcing and group-work. He calls his live presentations Keyshops. Online he involves participants as good as possible.
Eric regularly conducts workshops and learning sessions for professionals all around the globe. He wrote ‘Into the Heart of Meetings’ referred to as the bible of the changing meeting industry. In 2023 ‘Meetings, by Default or by Design’ was released. A book offering design solutions in 40 different aspects of meetings.
Anne Müller, Universität Zürich, CH
Anne Müller studied Biology at the University of Würzburg and received her PhD in Microbiology at the Max Planck Institute for Infection Biology in Berlin. She pursued postdoctoral studies at Stanford University in the lab of Stanley Falkow. She currently serves as Full Professor of Experimental Medicine and member of the Board of Directors of the Institute of Molecular Cancer Research at the University of Zurich. Her research interests include infection-induced cancers and host-pathogen interactions at mucosal surfaces, as well as the pathogenesis of B-cell lymphomas.
Christa Schleper, University of Vienna, AT
Christa Schleper is professor at the University of Vienna since 2007 and Head of the Archaea Biology and Ecogenomics Unit in the Faculty of Life Sciences. She was educated at the Universities of Aachen and Konstanz in Germany and did her PhD at the Max-Planck-Institute in Martinsried. After a Postdoc in California with Ed Delong she was assistant professor in Darmstadt and full professor in Bergen, Norway.
Christa has >25 years of experience with archaea. She studies the ecology and evolution of Thaumarchaeota and the newly discovered Asgardarchaea, as well as CRISPR defense systems in hyperthermophiles. Her major focus over the past 20 years was on the study of ammonia oxidizing archaea, that together with bacteria have great influence on the global nitrogen cycle, and play an important role in agriculture and the overfertilization problem. Christa is a member of the Austrian Academy of Sciences, the American and European Academies of Microbiology and EMBO and received the Austrian Wittgensteinpreis in 2022.
Christa is engaged in climate activities at the University of Vienna and education and gives also public talks on the environmental challenge and connection of overfertilization, food consumption and the nitrogen cycle.
Wilfried Posch, Medical University of Innsbruck, AT
Wilfried Posch is Associate Professor of Emerging Infectious Diseases and the Head of the Department of Hygiene, Microbiology and Virology at the Medical University of Innsbruck, Innsbruck, Austria. Wilfried studied Molecular Biology and the focus of his PhD was the characterization of host-pathogen interactions. During his research stays at the University College London, London, UK and at the INSERM UMR-S945 in Paris, France, he could further develop his knowledge in infection biology, inflammation and immune regulation. In 2018, he received his Habilitation in Immunology and established a research group at the Institute of Hygiene and Medical Microbiology. He and his team have been working on developing novel strategies for investigating microbial infections using human 3D cell culture models. Due to his ample expertise in T cell immunity, the group is currently also interested in studying adaptive immune responses within 3D cell culture systems.
Anouk Willemsen, University of Vienna, AT
My research broadly focuses on virus evolution, genome evolution, and phylogenetics. I pay special attention to virus-host co-evolution, the evolution and origin of specific genes, and the phenotypic consequences of genotypic novelty. Viruses are obligate intracellular parasites infecting organisms across the three domains of life (Archaea, Bacteria and Eukarya). New viruses are continuously being discovered, and it has become apparent that they are virtually everywhere. Viruses are important drivers of ecosystem functioning, as viral infection can influence the evolution of their hosts and other organisms (including other viruses) interacting with these hosts.
Yvonne Nygård, VTT Technical Research Centre of Finland and Chalmers University of Technology, Sweden, FI
Yvonne Nygård has a PhD in Molecular Biotechnology from Aalto University and currently works as Research Professor at VTT Technical Research Centre of Finland and as Associate Professor at Chalmers University of Technology in Sweden. Moreover, she is the CSO of a fungal start-up, Cirkulär AB. Yvonne’s main research interest is to develop microbial cell factories for industrial applications. She combines systems and synthetic biology with high throughput screening using biofoundry based approaches. Her research team works mainly yeast and filamentous fungi and has developed various synbio tools including expression systems, CRISPR/Cas based genome editing approaches and biosensors to name a few.
Belén Pacheco Fiallos, IMP, AT
Belén is a molecular biologist and biochemist from Nicaragua, specializing in mRNA processing and export. She earned her PhD at the Research Institute of Molecular Pathology, working in the lab of Dr. Clemens Plaschka, where her research advanced the understanding of nuclear mRNP recognition and packaging. Her work focused on protein structure and function analysis through biochemistry and Cryo-EM. Currently, Belén is dedicated to visual science communication and is studying the mechanism of Toxin-Antidote elements in C. elegans in the lab of Dr. Alejandro Burga at Institute of Molecular Biotechnology.
Michael Baumschabl, ACIB GmbH, AT
Michael Baumschabl is born in Vienna and finished the master program biotechnology at the University of Natural Resources (BOKU) in Vienna. During his master studies he was student team leader at the first iGEM team from BOKU. Afterwards he conducted a PhD at the Department for Biotechnology at BOKU together with the Austrian Center of Industrial Biotechnology focusing on the improvement of the autotrophic Komagataella phaffii strains. After his PhD he moved to the Agrana Research and Innovation Center focusing on novel food proteins. Now he is back at the Austrian Center of industrial Biotechnology as a postdoctoral reasearcher conducting research in the field of white biotechnology.
Susan Gasser, ISREC Foundation and University of Lausanne, CH
Susan Gasser studied at the University of Chicago (biophysics) and then completed her PhD at the University of Basel (biochemistry; with G Schatz) before a postdoc at the University of Geneva, where she studied human chromosome structure. She was group leader at the Swiss Institute for Experimental Cancer Research (ISREC) in Lausanne from 1986 – 2001, then professor at the University of Geneva, before leading from 2004 – 2019, the Friedrich Miescher Institute for Biomedical Research in Basel. Under her direction the institute became one of the leading biomedical research institutes in Europe, excelling on topics of neuronal circuitry, epigenetics, cell fate decisions and quantitative biology. Her own research team contributed insights into heterochromatin and genome stability in C. elegans and yeast, until 2021. She is now professor invité at the University of Lausanne and Director of the ISREC Foundation (www.isrec.ch), where she helps foster translational cancer research at the Agora Cancer Research Institute. She participates in numerous review boards and advisory committees in Switzerland, across Europe and in Japan, and actively promotes programs to advance the careers of women scientists.
Chiara M. Herzog, Universität Innsbruck, GB
Dr. Chiara Herzog is a translational scientist at the intersection of computational biology and clinical research at the European Translational Oncology Prevention and Screening Institute (EUTOPS; Universität Innsbruck) and an honorary research fellow at the Institute for Women’s Health (University College London). Her work focuses on the association of epigenetics (DNA methylation) and other omics biomarkers with the exposome, cancer risk, and ageing. She is passionate about leveraging novel technologies and biomarkers for risk prediction, early detection, and monitoring of personalised preventive strategies to extend healthspan. She has been co-leading of one of the largest multi-omic human lifestyle intervention trials to date (TirolGESUND study, NCT05678426) and serves on the executive committee of the Biomarkers of Aging Consortium (agingconsortium.org). Prior to her current work, she obtained a degrees in Neuroscience and Molecular Medicine from the University of Edinburgh and Innsbruck Medical University, respectively.
Cathrine Hellerschmied, University of Vienna, AT
Cathrine Hellerschmied holds a BSc in Medicinal and Pharmaceutical Biotechnology and an MSc in Biotechnology from the University of Natural Resources and Life Sciences, Vienna. During her undergraduate studies she gained experience through internships and work as a student assistant across various scientific fields, including bioprocess analyses, plant biotechnology, and bioremediation. Her diverse background culminated in her Master’s thesis at the IFA-Tulln, where she contributed to the Underground Sun Conversion project in collaboration with RAG AG. During this project, she developed a protocol for the detection and identification of metabolically active methanogenic microbes capable of reducing carbon dioxide to methane in samples from anaerobic environments. This method was crucial in verifying the activity of methanogens at the hydrogen storage test site located 1,200 meters underground. Cathrine is currently pursuing a PhD in Microbiology at the Center of Microbiology and Environmental Systems Science (CeMESS) at the University of Vienna. Her research focuses on the growth dynamics of heterotrophic bacteria at the single-cell level (single cell mass and volume). She studies how variations in growth influence bacterial mortality caused by bacteriophage infection. In addition to her research, Cathrine is passionate about science outreach. She participated in numerous outreach events, including Kinder Uni, European Researcher’s Night and Long Night of Research.
Elma Dervic, Medical University Vienna & Complexity Science Hub, AT
Dr. Elma Hot Dervic is a postdoctoral fellow at the Complexity Science Hub and the Medical University of Vienna. Her interdisciplinary work spans network science, complexity science and the application of data science to real-world challenges. Elma is currently focused on two areas of research: analyzing medical data to uncover disease trajectories and investigating systemic risks within global supply chains.
Elma earned her PhD from the Medical University of Vienna in January 2023. Before her doctoral studies, she completed her bachelor’s and master’s degrees in electrical engineering at the University of Montenegro. While at the University of Montenegro, she was a junior researcher at the First Center of Excellence (BIO-ICT).
Beyond academia, Elma co-founded BeeAnd.me, an innovative IoT startup that leverages technology to assist beekeepers and promote the health of bee populations through data science.
A passionate advocate for the impact of technology on society, Elma is a three-time TEDx speaker, where she has shared her insights on using technology for positive change.
Elina Ikonen, University of Helsinki, FI
Elina Ikonen, MD PhD, is a Professor of Cell and Tissue Biology at the Faculty of Medicine and Chair of Helsinki BioImaging Platform of Helsinki Institute of Life Science at the University of Helsinki. Her research focuses on understanding the principles by which key membrane and storage lipids, such as cholesterol, sphingolipids and triacylglycerols, are distributed in mammalian cells. These basic concepts are of fundamental importance for normal cellular functions and disturbances therein are associated with major human health threats, such as cardiovascular diseases and metabolic complications of obesity. Her group also develops, in collaborative efforts with biophysicists, organic chemists and molecular engineers, novel techniques for improved detection and analysis of cellular lipids. Her work has contributed to fundamental principles in the field of membrane lipid biology, and her findings have led to increased understanding of lipid-related disease mechanisms and to inventions for improving the detection or manipulation of lipids in the cellular and tissue context and treating dysregulated cholesterol homeostasis. Prof. Ikonen participates actively in advancing European science policies, e.g. as a scientific advisory committee member of EMBL and director of European research consortia.
Carol Munro, University of Aberdeen, GB
Carol Munro has a personal chair in Microbiology at the Institute of Medical Sciences, University of Aberdeen and is leader of the Microbiology & Immunity Research Theme. Carol is part of the Aberdeen Fungal Group and has over 25 years research experience investigating human fungal pathogens. Her research focusses on how fungal cell surface components contribute to virulence, host interactions, antifungal drug tolerance and resistance. Prof Munro has published 140 scientific publications, book chapters and reviews. She is Deputy Editor-in-Chief for FEMS Yeast Research, and is on the Microbiology Society’s Impact and Influence Committee.
Over the years Prof Munro’s group have worked with a number of anti-infectives companies through industrial-funded studentships, Knowledge Transfer Partnerships and fees-for-service contracts. Carol, with partners at the Scottish Biologics Facility, has developed a proprietary drug development pipeline and exploited this to discover novel biologics-based antifungal immunotherapeutics that target the fungal cell wall. The team has received funding from Scottish Enterprise, BBSRC iCure Explore programme and Innovate UK for pre-clinical development of their antifungal antibodies with plans to spin-out a company Brigid Biologics.
Nektarios Tavernarakis, 1. Foundation for Research and Technology - Hellas. 2. University of Crete., GR
Nektarios Tavernarakis is Professor of Molecular Systems Biology at the Medical School of the University of Crete. He is also the Chairman of the Board of Directors at the Foundation for Research and Technology-Hellas (FORTH), and Research Director at the Institute of Molecular Biology and Biotechnology (IMBB), where he is heading the Neurogenetics & Ageing laboratory. He has served as Chairman of the European Institute of Innovation and Technology (EIT) Governing Board, as Vice President of the Scientific Council of the European Research Council (ERC), and Director of IMBB. He is a member of the American Association for the Advancement of Science (AAAS), the European Molecular Biology Organization (EMBO), the German National Academy of Sciences (Leopoldina), among others. His work focuses on the molecular mechanisms of necrotic cell death and neurodegeneration, the interplay between cellular metabolism and ageing, the mechanisms of sensory transduction and integration by the nervous system, and the development of novel genetic tools for biomedical research. He has received several notable scientific prizes, including two ERC Advanced Investigator Grants, and an innovation-supporting ERC Proof of Concept Grant. He is the recipient of the EMBO Young Investigator award, the Alexander von Humboldt Foundation, Friedrich Wilhelm Bessel research award, the Scientific Prize for Medicine and Biology, the Excellence in Biomedical Sciences Award, of the Bodossaki Foundation, and many more.
Pavel Mykhailiuk, Enamine, UA
Pavel was born in Kerch, Ukraine. In 2009 he received PhD in biochemistry from Technical University of Karlsruhe (KIT, Germany) with Prof. Anne Ulrich; and PhD in organic Chemistry from Kyiv National Taras Shevchenko University (Ukraine) with Prof. Igor Komarov.
In 2009, Pavel returned to Ukraine and joined “Enamine” company, where he is currently involved into discovery of novel building blocks for drug design.
Pavel´s research interests include fluoroorganic chemistry, chemistry of diazo compounds, photochemistry and saturated bioisosteres of the benzene. He is co-author of more than 100 peer-reviewed research manuscripts. In 2017, he received Dr.Sci. in organic chemistry from the Kyiv National Taras Shevchenko University.
Sebastian Leidel, University of Bern, CH
Sebastian Leidel is Full Professor of Cellular RNA Biochemistry at the University of Bern. He studied Protestant Theology in Siegen, Marburg, Jerusalem and Heidelberg and Cell and Molecular Biology at Heidelberg University. After completing his master’s thesis at the University of Pennsylvania, he joined the laboratory of Pierre Gönczy at the Swiss Institute for Experimental Cancer Research for his Ph.D, where he studied the role of SAS proteins in centrosome duplication in C. elegans. More and more attracted by biochemistry, he did postdoctoral work at the Institute of Biochemistry at ETH Zurich, where he discovered that ubiquitin-related modifier 1 (Urm1) acts as a sulfur carrier during the modification of cytoplasmic tRNA in eukaryotes. In 2008, he became a lecturer at the Institute of Biochemistry at the ETH Zurich before starting a Max Planck Research Group at the Max Planck Institute for Molecular Biomedicine in Münster in 2009. There he continued his work on tRNA modifications and cellular quality control. He received an ERC Starting Grant in 2012 and was appointed full professor at the University of Bern in 2018. In 2019 he became an elected member of the Academia Europaea.
Gustav Vaaje-Kolstad, Norwegian University of Life Sciences, NO
Gustav Vaaje-Kolstad is a professor of biotechnology and the deputy leader of the Protein Engineering and Proteomics group at the Norwegian University of Life Sciences. Throughout his career, he has specialized in carbohydrate-active enzymes, most notably discovering lytic polysaccharide monooxygenases (LPMOs). His research interests also include the deconstruction and application of novel exopolysaccharides, as well as the synthesis and enzymatic depolymerization of synthetic polymers.
Valter D. Longo, University of Southern California, US
Dr. Valter Longo is internationally recognized as a leader in the field of longevity and age-related diseases.
His laboratory described and developed the fasting-mimicking diet and published on its effect on multi-system stem cell activation, reprogramming, and regeneration. This led to over 30 clinical trials on longevity and age-related disease, some demonstrating the effect of fasting-mimicking diet cycles inreducing biological age, causing diabetes regression, and potentially increasing survival in cancer patients.
Dr. Longo is a Professor of Gerontology and Biological Science and Director of the Longevity Institute at the School of Gerontology of the University of Southern California in Los Angeles, one of the world’s leading centers devoted to teaching and research on aging.
His book, “The Longevity Diet”, is an international bestseller, translated into over 25 languages and sold in more than 30countries around the globe. In 2018 he was included among the 50 most influential people in healthcare by TIME magazine.
He is the founder of the non-profit organizations Create Cures Foundation in the US and the Valter Longo Foundation in Italy, which provide lifestyle education for children and adults, and nutritional assistance to optimize healthy longevity.
Susan Howlett, Dalhousie University, CA
Susan Howlett is Professor of Pharmacology and Geriatric Medicine at Dalhousie University in Halifax where she has taught for more than 30 years. Her laboratory is recognized for work on cardiac excitation-contraction coupling. She has discovered profound differences in male and female heart cell function, how these change with age and how sex hormones regulate these processes. Her lab has pioneered the measurement of frailty in naturally aging animals with a novel "frailty index" (FI) tool based on deficit accumulation. Her work shows that maladaptive, age-dependent changes in heart structure and function are better graded by the level of frailty than by age itself. Critically, cardiac aging and frailty are linked to inflammation in a highly sex-specific fashion. Her work shows polypharmacy exacerbates mouse frailty, while deprescribing, exercise or geroprotector drugs attenuate frailty. A translational scientist, she has used results from animal studies to develop a new tool based on lab results (the FI-Lab) to measure frailty in people. As a frequent contributor to prominent journals (H-index 55), editor, reviewer and editorialist, Susan has a wide view of research across the life course in both sexes. Her personal and collaborative experience allows insight into the needs of researchers across the career span. Her mentorship of now generations of young scientists, the great bulk of whom have pursued academic careers, speaks to her ability to inspire young researchers.
Nataliia Maronchuk, Medical University of Innsbruck, University Clinic for Psychiatry I, AT
Nataliia Maronchuk, MSc.
University assistant
Clinical Psychologist in specialist training
PhD Student in Medical Psychology
@: This email address is being protected from spambots. You need JavaScript enabled to view it.
EDUCATION
10.2022 – ongoing – PhD Program in Medical Psychology/ Medical University Innsbruck (MUI), Austria
10.2021 – ongoing – Clinical Psychology postgraduate course/ Austrian Academy of Psychology (AAP), Austria
10.2016 – 07.2021 – Master of sciences in Psychology/ UMIT Hall in Tirol, The Tyrolean Private University, Austria
09.1998 – 07.2004 – Master of sciences in economics/ Taras Shevchenko National University of Kyiv, Ukraine
MAIN RESEARCH AREAS AND INTERESTS
Resilience, Coping with stress, Interventions for stress management, effects of electroconvulsive therapy on cognitive function, Affective Disorders, Schizophrenia
Juliane Winkler, Medical University of Vienna, AT
Dr. Juliane Winkler is a Group Leader at the Center for Cancer Research of the Medical University of Vienna. She is a trained Pharmacist and received her Ph.D. from the University of Heidelberg (jointly EMBL, German Cancer Research Center, and Institute of Pathology), where she studied how nuclear transport alterations promote aggressive hepatocellular carcinoma (HCC). In her postdoc at the University of California San Francisco, Dr. Winkler worked with the late Zena Werb and Andrei Goga on the impact of tumor heterogeneity on breast cancer metastasis and developed and applied novel single-cell omics technologies. The Winkler lab is using single-cell omics and spatial technologies to understand the implications of tumor heterogeneity on the formation and progression of metastasis and metastatic niches.
Juliane Winkler, Medical University of Vienna, AT
Dr. Juliane Winkler is a Group Leader at the Center for Cancer Research of the Medical University of Vienna. She is a trained Pharmacist and received her Ph.D. from the University of Heidelberg (jointly EMBL, German Cancer Research Center, and Institute of Pathology), where she studied how nuclear transport alterations promote aggressive hepatocellular carcinoma (HCC). In her postdoc at the University of California San Francisco, Dr. Winkler worked with the late Zena Werb and Andrei Goga on the impact of tumor heterogeneity on breast cancer metastasis and developed and applied novel single-cell omics technologies. The Winkler lab is using single-cell omics and spatial technologies to understand the implications of tumor heterogeneity on the formation and progression of metastasis and metastatic niches.
David Schönauer, Aminoverse, NL
David started his entrepreneurial career in 2012 as CEO of the german university spin-off SeSaM-Biotech GmbH to follow his scientific passion - enzymes. He ran the company specialized in enzyme development by Directed Evolution in parallel to his studies at RWTH Aachen University, Germany, where he graduated in 2014 in Molecular and Applied Biotechnology among the top 5% of all university students of the year for which he was awarded the "Springorum Denkmünze".
While growing SeSaM-Biotech organically from 1 to 10 employees over 7.5 years, David sought to integrate artificial intelligence into enzyme development which led to the foundation of his own company Aminoverse in March 2020.
To date, the venture capital-free company counts 19 people and offers dedicated enzyme R&D services by combining wet lab, biophysics and AI. A major milestone was the achievement of profitability after just 3.5 years in 2023.
Johannes Grillari, Ludwig Boltzmann Institute for Traumatology, AT
Johannes Grillari is director of the Ludwig Boltzmann Institute for Traumatology. The Research Center in cooperation with AUVA and associate Professor at the Dept. of Biotechnology at BOKU University Vienna. His research interest is on improving our understanding of the molecular and physiological changes that occur during cellular aging, their impact on organismal aging and tissue regeneration. His work has pioneered the role of miRNAs in cellular senescence, bone and skin regeneration, showing that extracellular vesicles and their cargo, especially their miRNA cargo are inhibitors of regeneration when from senescent cells, while they have therapeutic effects when coming from mesenchymal stroma cells. He was also instrumental in designing targeting EVs for regenerative medicine purposes. He has authored and co-authored more than 230 SCI publications and 15 patents. He is also co-founder of companies in the space of cellular senescence and extracellular vesicles.
Cecilia Dominguez Conde, Human Technopole, IT
Cecilia Domínguez Conde is a Group Leader at the Population & Medical Genomics programme of the Genomics Centre at Human Technopole (HT) in Milan. After training as a pharmacist in the University of Seville, Cecilia went on to do a PhD in Immunology at the Research Centre for Molecular Medicine (CeMM) in Vienna where her work focused on dissecting the genetic cause of molecularly undiagnosed primary immunodeficiencies using exome sequencing. In 2019 Cecilia joined the Teichmann lab at the Wellcome Sanger Institute where her focus has been to dissect the diversity of human immune cell types across lymphoid and non-lymphoid tissues as part of the Human Cell Atlas initiative. Her research group at HT, established in 2022, uses cutting-edge genomic technologies to study developmental immunology in health and disease.
Florian Schur, Institute of Science and Technology Austria, AT
Florian is an Assistant Professor at the Institute of Science and Technology Austria (ISTA).
His lab aims to integrate cell and structural biology approaches to understand how higher-order protein assemblies are defined by the interplay between inter-molecular interactions and the geometrical/architectural boundary conditions of the biological system. Specifically, the lab studies the molecular organization of mechanisms that control cell migration and viral infection. To this end, the Schur lab develops new approaches in cellular cryo-electron microscopy, including specimen preparation, data analysis and high-resolution structure determination.
The research of Florian’s lab is supported by different national and international grants, including a ChanZuckerberg Initiative grant, an ERC Starting grant and an FWF Emerging Fields grant.
Florian is an EMBO Young Investigator and a recipient of the FEBS Excellence Award.
Georg Guebitz, BOKU University, AT
Prof. Dr. Georg M. Guebitz obtained his PhD in Biotechnology from TU-Graz, Austria in 1996. As an Erwin-Schroedinger Fellow he investigated enzymatic strategies related to lignocellulose processing at University of British Columbia, Canada from 1996 – 98. Since 2013, he holds a full professorship at BOKU-Vienna, and is the head of the Department of Agrobiotechnology, IFA Tulln. Guebitz’s research is focused on on biotechnical functionalization, processing and recycling of materials. In this area, Guebitz has published more than 450 papers in peer reviewed journals (h-index 77, Scopus), he holds 15 patents and has edited various books and has received more than 20 prestigious awards. He participated in 35 European projects and coordinated 8.
Andy Martin, UC Berkeley, Howard Hughes Medical Institute, US
Andy Martin did his undergraduate studies in Biochemistry at the University of Bayreuth, Germany, where he also received his Ph.D. in 2003, focusing on protein folding and directed evolution. From 2003 to 2008 he pursued postdoctoral studies in the Biology Department at MIT, where he investigated the mechanisms of ATP hydrolysis, substrate recognition, and degradation by the bacterial AAA+ protease ClpXP. In 2008 Dr. Martin became a faculty member in the Department of Molecular & Cell Biology at UC Berkeley, and since 2015 he has been an investigator of the Howard Hughes Medical Institute. His research focuses on the structure and function of AAA+ proteases and protein translocases, with a main emphasis on the ubiquitin-proteasome system.
Social Program
Social Program
Wine & Science reception on Sept. 17th, 2024
The ÖGMBT Annual Meeting is also famous for its “Wine & Science” reception (Tuesday evening, September 19), which is included in the registration fee. This welcome reception is held within the industry exhibition area. The exhibitors bring along wine for tasting with the participants and ÖGMBT takes care of cheese and desserts. There are many wine specialties to taste and we have already counted at one of the tastings about 120 different varieties - but don't worry, there are also non-alcoholic offers ;-) Just join and enjoy the networking!
City walk & Rooftop Reception on Sept. 18th, 2024
Where: Schlossberg/Café FREIBLICK
When: Wednesday 18.9., 17:45 - 23:00 Uhr
Exploring the beautiful town of Graz we will take a guided walk (approx. 1,5 h). Enjoying the view from top of the "Schloßberg" we will learn some historic facts about the city and those who dare can use the famous slide downhills (https://www.youtube.com/watch?v=Ah9RvV2qjIU; 6€ entry fee). The tours will be divided into various levels of difficulty (fitness wise), separated in English and German speakers and local scientists and professional guides will take on introducing Graz to you.
All groups will end up in one of Graz' fanciest hotspots the Roof Top Tagescafé "FREIBLICK" (https://tinyurl.com/299ggxjv). There a representative of the city of Graz, who kindly sponsored part of this event, will welcome us and upon entry you'll be served a first drink - this one is on us. You can choose between white wine spritz, beer, and none alcoholic limonade. Use this chance to network and socialize while we treat you to delicious flying finger food. The adventurous ones have the chance to step on the Skywalk and even see Graz' main square from the café's roof top.
Space is limited. So kindly sign in on our event list at the registration desk upon onsite registration. Kindly be aware that admission will only be granted showing your conference badge. We are very much looking forward enjoying a lovely evening with all of you.
Industry Exhibition
Industry Exhibition
The industry exhibition located in the foyers of ReSoWi center and university library with companies and institutions showcasing their products & services for the life sciences community.
Exhibitor Quiz
All meeting attendees can take part in the exhibitor quiz and win prizes. Each participating exhibitor prepared a question and the correct answer can be found at their respective booth confirming. Only quiz sheets with all the correct answers and stamps from every participating booth will be taking into consideration for the lottery drawing of the prizes sponsored by the exhibitors. On Thursday, Sept 19, there will be two prize drawings:
- The first drawing of the less valuable prizes will take place during the last lunch break
- The three winners of the main quiz prizes will be awarded during the closing ceremony
Workshops
Workshops
Glacios 2 and SmartEPU automation for accessible, high-throughput structure determination and drug discovery
by Javier Fernandez Collado, Thermo Fisher Scientific
Sept 19, 12:50 - 13:20, Lecture room: UB Alumni HS
Cryo-EM has revolutionized biology by resolving protein structures at high resolutions. The Glacios 2 Cryo-TEM equipped with Smart EPU software enables users of all levels of expertise to obtain high resolution data. In collaboration with the Greber lab (Institute for Cancer Research), the structure of CDK-activating kinase (CAK) bound to different ligands was rapidly resolved to ∼4 Å and ∼3 Å resolutions using 1-hour and 4-hour sessions. Greater user accessibility and increased throughput enable cryo-EM to drive structure-based drug discovery. Additionally, the state-of-the-art E-CFEG pushes resolution even further, achieving the record at 200 kV with a 1.5 Å reconstruction of Apoferritin.
LabBuddy: Transform Your Laboratory Education with a Cutting-Edge Digitalization Tool
by Anita Emmerstorfer-Augustin & Robert Kourist, key organizeers of the laboratory course at TUGraz that uses LabBuddy
Sept 19, 12:50 - 13:20, Lecture room: ReSoWi HS 15.03
Teachers of lab courses often face challenges such as low motivation, large classes, and underprepared students, which leads to increased work pressure. While modern teaching practices and digital tools can help, the implementation in lab courses is particularly challenging due to their complexity. The e-learning solution LabBuddy enhances education through blended learning. It prepares students before they begin their practical work, supports them during lab activities, and guides them through the analysis of their results afterward. In this presentation, we'll showcase our successful implementation of LabBuddy in the NAWI Graz Laboratory Course ‘Introduction to Molecular Biology I (MOL.501)’. We will also highlight the benefits and improvements achieved by applying modern digitalization tools.
Target audience:
At the ÖGMBT Meeting, the audience will primarily consist of university professionals, and the presentation will be of interest to many attendees—particularly lecturers, as well as students at the Bachelor, Master, and PhD levels.
Pre-event 16.9.
Pre-event to the Annual Meeting taking place on the 16th of September 2024
Monday, September 16th, 2024
|
13:40 - 17:00 |
Workshop 16.9.: Event Design for young scientists - when just organising is not enough
Eric de Groot (MindMeeting BV, NL)
|
ReSoWi LS 15.03 |
ÖGMBT YLSA Workshop: Event Design for young scientists - when just organising is not enough
Sponsored by
Where: ReSoWi LS 15.03
When: Monday 16.9., 13:40-17:00
This workshop, by Dutch Meeting Designer and author Eric de Groot, opens the world of designing meetings. If organising an event and designing it are two different things, different mindsets are needed. The organiser needs to be, well, very organised, whilst the designer can do with a bit of chaos, creativity and lateral thinking. In the world of constructing, the builder and architect are two different professions. In the world of events making that distinction can profoundly help. Design is needed if serving drinks is not enough to stimulate networking, if a frontal PowerPoint presentation is not enough to ignite an academic exploration, if a CEO speech is not enough to boost motivation. This workshop will help you to leave the default programming by analysing what is needed to design a great event program.
Booking the workshop: After registering for the annual meeting and paying any open registration fees the workshop can be booked in the registration system under "Workshops Registration".
UPDATE: Advanced cell culture workshop
The workshop on "Advanced Cell Culture Technologies” will not be held at the ÖGMBT annual meeting 2024 but will instead take place as a separate event in spring 2025.